Greenleaf Trust’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.76M | Sell |
121,466
-1,329
| -1% | -$17.9K | 0.02% | 238 |
|
|
2026
Q1 | $1.7M | Buy |
122,795
+611
| +0.5% | +$8.51K | 0.02% | 225 |
|
|
2025
Q4 | $1.72M | Buy |
122,184
+3,769
| +3% | +$52.9K | 0.02% | 233 |
|
|
2025
Q3 | $1.66M | Sell |
118,415
-54
| -0% | -$777 | 0.02% | 236 |
|
|
2025
Q2 | $1.78M | Buy |
118,469
+1,028
| +0.9% | +$14.7K | 0.02% | 219 |
|
|
2025
Q1 | $1.55M | Sell |
117,441
-170
| -0.1% | -$2.35K | 0.01% | 241 |
|
|
2024
Q4 | $1.86M | Buy |
117,611
+121
| +0.1% | +$1.82K | 0.02% | 209 |
|
|
2024
Q3 | $1.87M | Hold |
117,490
| – | – | 0.02% | 213 |
|
|
2024
Q2 | $1.79M | Buy |
117,490
+50
| +0% | +$717 | 0.02% | 198 |
|
|
2024
Q1 | $1.72M | Buy |
117,440
+290
| +0.2% | +$4.23K | 0.02% | 200 |
|
|
2023
Q4 | $1.63M | Sell |
117,150
-345
| -0.3% | -$4.61K | 0.02% | 209 |
|
|
2023
Q3 | $1.57M | Sell |
117,495
-1,450
| -1% | -$19.6K | 0.02% | 191 |
|
|
2023
Q2 | $1.5M | Buy |
118,945
+255
| +0.2% | +$2.98K | 0.02% | 206 |
|
|
2023
Q1 | $1.35M | Sell |
118,690
-290
| -0.2% | -$3.13K | 0.02% | 229 |
|
|
2022
Q4 | $1.23M | Buy |
118,980
+465
| +0.4% | +$5.02K | 0.02% | 231 |
|
|
2022
Q3 | $1.24M | Buy |
118,515
+220
| +0.2% | +$2.34K | 0.02% | 204 |
|
|
2022
Q2 | $1.31M | Sell |
118,295
-8,785
| -7% | -$95.5K | 0.02% | 186 |
|
|
2022
Q1 | $1.42M | Sell |
127,080
-12,730
| -9% | -$144K | 0.02% | 186 |
|
|
2021
Q4 | $1.83M | Buy |
139,810
+16,800
| +14% | +$212K | 0.02% | 146 |
|
|
2021
Q3 | $1.6M | Sell |
123,010
-1,870
| -1% | -$24.9K | 0.02% | 152 |
|
|
2021
Q2 | $1.84M | Sell |
124,880
-130
| -0.1% | -$1.82K | 0.02% | 136 |
|
|
2021
Q1 | $1.53M | Hold |
125,010
| – | – | 0.02% | 146 |
|
|
2020
Q4 | $1.78M | Sell |
125,010
-750
| -0.6% | -$10.1K | 0.02% | 119 |
|
|
2020
Q3 | $1.75M | Buy |
125,760
+1,225
| +1% | +$14.6K | 0.03% | 112 |
|
|
2020
Q2 | $1.32M | Buy |
124,535
+860
| +0.7% | +$8.75K | 0.02% | 127 |
|
|
2020
Q1 | $998K | Buy |
123,675
+41,580
| +51% | +$347K | 0.02% | 131 |
|
|
2019
Q4 | $666K | Buy |
82,095
+39,240
| +92% | +$310K | 0.01% | 230 |
|
|
2019
Q3 | $325K | Buy |
42,855
+295
| +0.7% | +$2.19K | 0.01% | 385 |
|
|
2019
Q2 | $319K | Buy |
42,560
+1,645
| +4% | +$12.9K | 0.01% | 388 |
|
|
2019
Q1 | $331K | Sell |
40,915
-13,830
| -25% | -$105K | 0.01% | 363 |
|
|
2018
Q4 | $413K | Buy |
54,745
+12,850
| +31% | +$90.4K | 0.01% | 296 |
|
|
2018
Q3 | $290K | Buy |
41,895
+8,355
| +25% | +$55.8K | 0.01% | 404 |
|
|
2018
Q2 | $216K | Sell |
33,540
-35,255
| -51% | -$222K | ﹤0.01% | 456 |
|
|
2018
Q1 | $450K | Buy |
68,795
+6,230
| +10% | +$43.7K | 0.01% | 255 |
|
|
2017
Q4 | $470K | Sell |
62,565
-5,770
| -8% | -$41.6K | 0.01% | 255 |
|
|
2017
Q3 | $488K | Buy |
+68,335
| New | +$491K | 0.01% | 239 |
|
Other funds holding RDY
AIM
Greenleaf Trust's RDY Position: Q2 2026 in Review
Greenleaf Trust reduced its Dr. Reddy's Laboratories (RDY) stake by 1.1% in Q2 2026, selling an estimated $17.9K and leaving 121,466 shares worth $1.76M. The position accounts for 0.02% of the portfolio, ranked #238.
Greenleaf Trust first reported a position in RDY in Q3 2017 and has held it in 36 quarters since. The position peaked at $1.87M in Q3 2024. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Greenleaf Trust held 121,466 shares of Dr. Reddy's Laboratories worth $1.76M as of Q2 2026.
- Greenleaf Trust sold 1,329 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $17.9K.
- Dr. Reddy's Laboratories made up 0.02% of Greenleaf Trust's portfolio in Q2 2026, its #238 holding.
- Greenleaf Trust first reported a position in Dr. Reddy's Laboratories in Q3 2017 and has held it in 36 quarters since.
- Greenleaf Trust's Dr. Reddy's Laboratories position peaked at $1.87M in Q3 2024.
- 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.